A carregar...

Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated Proteins

The ability to selectively and directly target activated Ras would provide immense utility for treatment of the numerous cancers that are driven by oncogenic Ras mutations. Patients with disorders driven by overactivated wild-type Ras proteins, such as type 1 neurofibromatosis, might also benefit fr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Mattingly, Raymond R.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3833460/
https://ncbi.nlm.nih.gov/pubmed/24294527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/536529
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!